Moss David J
Insider CIK 1421930 · INMB Chief Financial Officer, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INMB Inmune Bio, Inc. | X Exercise deriv | 2026-07-02 | 2026-07-07 | 9,014 | $0.13 | $1.2K | 9,014 | SEC↗ |
| INMB Inmune Bio, Inc. | M Exercise | 2026-07-02 | 2026-07-07 | 9,014 | $1.40 | $12.6K | 1,294,883 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2025-12-01 | 2025-12-02 | 750,000 | — | $0 | 750,000 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2025-11-18 | 2025-11-18 | 70,663 | — | $0 | 70,663 | SEC↗ |
| INMB Inmune Bio, Inc. | D To issuer deriv | 2025-11-18 | 2025-11-18 | 70,663 | — | $0 | 0 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2025-11-18 | 2025-11-18 | 275,000 | — | $0 | 275,000 | SEC↗ |
| INMB Inmune Bio, Inc. | D To issuer deriv | 2025-11-18 | 2025-11-18 | 275,000 | — | $0 | 0 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2025-11-18 | 2025-11-18 | 59,337 | — | $0 | 59,337 | SEC↗ |
| INMB Inmune Bio, Inc. | D To issuer deriv | 2025-11-18 | 2025-11-18 | 59,337 | — | $0 | 0 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2025-11-18 | 2025-11-18 | 400,000 | — | $0 | 400,000 | SEC↗ |
| INMB Inmune Bio, Inc. | D To issuer deriv | 2025-11-18 | 2025-11-18 | 400,000 | — | $0 | 0 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2025-11-18 | 2025-11-18 | 160,000 | — | $0 | 160,000 | SEC↗ |
| INMB Inmune Bio, Inc. | D To issuer deriv | 2025-11-18 | 2025-11-18 | 160,000 | — | $0 | 0 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2025-11-18 | 2025-11-18 | 223,000 | — | $0 | 223,000 | SEC↗ |
| INMB Inmune Bio, Inc. | D To issuer deriv | 2025-11-18 | 2025-11-18 | 223,000 | — | $0 | 0 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2025-11-18 | 2025-11-18 | 130,000 | — | $0 | 130,000 | SEC↗ |
| INMB Inmune Bio, Inc. | D To issuer deriv | 2025-11-18 | 2025-11-18 | 130,000 | — | $0 | 0 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2025-11-18 | 2025-11-18 | 160,000 | — | $0 | 160,000 | SEC↗ |
| INMB Inmune Bio, Inc. | D To issuer deriv | 2025-11-18 | 2025-11-18 | 160,000 | — | $0 | 0 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2024-12-05 | 2024-12-09 | 223,000 | — | $0 | 223,000 | SEC↗ |
| INMB Inmune Bio, Inc. | P Buy | 2024-09-30 | 2024-09-30 | 10,000 | $5.29 | $52.9K | 1,285,869 | SEC↗ |
| INMB Inmune Bio, Inc. | P Buy deriv | 2024-09-12 | 2024-09-16 | 7,690 | $0.13 | $1000 | 7,690 | SEC↗ |
| INMB Inmune Bio, Inc. | P Buy | 2024-09-12 | 2024-09-16 | 7,690 | $6.38 | $49.1K | 1,275,869 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2024-05-14 | 2024-05-16 | 160,000 | — | $0 | 160,000 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2024-04-19 | 2024-04-23 | 18,028 | $0.13 | $2.3K | 18,028 | SEC↗ |
| INMB Inmune Bio, Inc. | P Buy deriv | 2024-04-19 | 2024-04-24 | 18,028 | $0.13 | $2.3K | 18,028 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award | 2024-04-19 | 2024-04-23 | 18,028 | $8.32 | $150.0K | 1,268,179 | SEC↗ |
| INMB Inmune Bio, Inc. | P Buy | 2024-04-19 | 2024-04-24 | 18,028 | $8.32 | $150.0K | 1,268,179 | SEC↗ |
| INMB Inmune Bio, Inc. | P Buy | 2023-03-17 | 2023-03-20 | 2,500 | $6.43 | $16.1K | 1,250,151 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2023-02-16 | 2023-02-21 | 160,000 | — | $0 | 160,000 | SEC↗ |
| INMB Inmune Bio, Inc. | P Buy | 2022-05-27 | 2022-05-31 | 3,000 | $6.79 | $20.4K | 1,247,651 | SEC↗ |
| INMB Inmune Bio, Inc. | P Buy | 2022-05-26 | 2022-05-31 | 7,700 | $6.27 | $48.3K | 1,244,651 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award | 2022-03-22 | 2022-03-23 | 17,793 | $8.43 | $150.0K | 1,236,951 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2022-03-21 | 2022-03-23 | 130,000 | — | $0 | 130,000 | SEC↗ |
| INMB Inmune Bio, Inc. | S Sale | 2021-11-03 | 2021-11-04 | 1,025 | $20.00 | $20.5K | 1,219,158 | SEC↗ |
| INMB Inmune Bio, Inc. | S Sale | 2021-10-27 | 2021-10-29 | 2,079 | $20.00 | $41.6K | 1,220,183 | SEC↗ |
| INMB Inmune Bio, Inc. | S Sale | 2021-10-25 | 2021-10-26 | 13 | $20.00 | $260 | 1,222,262 | SEC↗ |
| INMB Inmune Bio, Inc. | S Sale | 2021-10-22 | 2021-10-26 | 1,142 | $20.00 | $22.8K | 1,222,275 | SEC↗ |
| INMB Inmune Bio, Inc. | M Exercise deriv | 2021-07-16 | 2021-07-19 | 25,000 | — | $0 | 275,000 | SEC↗ |
| INMB Inmune Bio, Inc. | M Exercise | 2021-07-16 | 2021-07-19 | 25,000 | $3.91 | $97.8K | 1,223,417 | SEC↗ |
| INMB Inmune Bio, Inc. | S Sale | 2021-07-08 | 2021-07-09 | 16,302 | $20.09 | $327.5K | 1,198,417 | SEC↗ |
| INMB Inmune Bio, Inc. | S Sale | 2021-07-07 | 2021-07-09 | 8,698 | $20.01 | $174.0K | 1,214,719 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2021-06-22 | 2021-06-24 | 70,663 | — | $0 | 70,663 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2021-01-19 | 2021-01-21 | 59,337 | — | $0 | 59,337 | SEC↗ |
| INMB Inmune Bio, Inc. | A Award deriv | 2019-11-25 | 2019-11-27 | 300,000 | — | $0 | 700,000 | SEC↗ |
| INMB Inmune Bio, Inc. | P Buy | 2019-08-20 | 2019-08-21 | 376 | $5.65 | $2.1K | 1,223,417 | SEC↗ |
| INMB Inmune Bio, Inc. | P Buy | 2019-08-20 | 2019-08-21 | 236 | $5.65 | $1.3K | 1,223,041 | SEC↗ |
| INMB Inmune Bio, Inc. | P Buy | 2019-08-20 | 2019-08-21 | 77 | $5.65 | $435 | 1,220,494 | SEC↗ |
| INMB Inmune Bio, Inc. | P Buy | 2019-08-20 | 2019-08-21 | 239 | $5.65 | $1.4K | 1,220,733 | SEC↗ |
| INMB Inmune Bio, Inc. | P Buy | 2019-08-20 | 2019-08-21 | 2,000 | $5.65 | $11.3K | 1,222,733 | SEC↗ |
| INMB Inmune Bio, Inc. | P Buy | 2019-08-20 | 2019-08-21 | 72 | $5.65 | $407 | 1,222,805 | SEC↗ |
| INMB Inmune Bio, Inc. | P Buy | 2019-06-03 | 2019-06-04 | 10,000 | $6.00 | $60.0K | 1,220,417 | SEC↗ |
| INMB Inmune Bio, Inc. | P Buy | 2019-05-06 | 2019-05-07 | 5,000 | $9.00 | $45.0K | 1,210,417 | SEC↗ |
| INMB Inmune Bio, Inc. | P Buy | 2019-05-06 | 2019-05-20 | 5,000 | $10.71 | $53.6K | 1,210,417 | SEC↗ |